Literature DB >> 2711122

Outer membranous vesicles and leukotoxic activity of Actinobacillus actinomycetemcomitans from subjects with different periodontal status.

B Tervahartiala1, V J Uitto, K Kari, T Laakso.   

Abstract

Strains of A. actinomycetemcomitans (A.a) from juvenile periodontitis patients (JP), adult periodontitis patients (AP), and 14-yr-old healthy children were tested for the correlation between leukotoxin activity and the number of outer membranous vesicles measured in electron micrographs. To determine the potential for connective tissue destruction following the interaction of polymorphonuclear leukocytes (PMN) with the bacteria, the lysosomal release of neutrophil elastase was assessed. The highest potential to kill leukocytes and to release lysosomal elastase from them was observed in the strains isolated from JP patients. No correlation existed between leukotoxic activity and the number of outer membranous vesicles per bacterium when the data from A.a. strains from all sources were combined. Furthermore, no significant differences were found between the numbers of outer membranous vesicles in the three groups tested. The only significant correlation between the number of vesicles and leukotoxicity was found in the A.a. strains derived from the mouths of healthy children.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2711122     DOI: 10.1111/j.1600-0722.1989.tb01428.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  2 in total

1.  Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue.

Authors:  T Into; M Inomata; Y Kanno; T Matsuyama; M Machigashira; Y Izumi; T Imamura; M Nakashima; T Noguchi; K Matsushita
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

2.  Intra- and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS.

Authors:  K P Fong; W O Chung; R J Lamont; D R Demuth
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.